PMID: 4152812Jan 1, 1974Paper

Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris

European Journal of Clinical Pharmacology
I NordenfeltS Persson

Abstract

No abstract listed.

References

Feb 1, 1974·European Journal of Pharmacology·K R AdamJ Linnell
May 16, 1970·British Medical Journal·C F GeorgeB L Pentecost
Nov 1, 1972·Clinical Pharmacology and Therapeutics·W S AronowM Khursheed
Sep 1, 1966·The American Journal of Cardiology·R H GrantK Sinclair
Sep 1, 1966·The American Journal of Cardiology·R RabkinM M Suzman
Sep 1, 1966·The American Journal of Cardiology·S WolfsonR Gorlin
Sep 1, 1966·The American Journal of Cardiology·J HAMER, E Sowton
Sep 19, 1964·British Medical Journal·J HAMERG E SOWTON
Sep 19, 1964·British Medical Journal·S C SRIVASTAVAD J NEWELL
Apr 3, 1965·British Medical Journal·P KEELAN
Aug 7, 1965·British Medical Journal·P M Gillam, B N Prichard

Citations

Nov 1, 1976·Progress in Cardiovascular Diseases·M E ConollyC T Dollery
Jan 15, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·H Karppanen

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Related Papers

JAMA : the Journal of the American Medical Association
L J Lyon, M A Nevins
JAMA : the Journal of the American Medical Association
E A AmsterdamS Wolfson
© 2021 Meta ULC. All rights reserved